Short Interest in Olympus Co. (OTCMKTS:OLYMY) Rises By 333,253.8%

Olympus Co. (OTCMKTS:OLYMY) was the target of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 43,336 shares, a growth of 333,253.8% from the June 30th total of 13 shares. Based on an average daily trading volume, of 117,586 shares, the days-to-cover ratio is presently 0.4 days.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group cut shares of Olympus from a “buy” rating to a “neutral” rating in a report on Monday, June 15th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has a consensus rating of “Hold”.

Olympus Price Performance

OLYMY stock traded up $0.17 during trading on Friday, hitting $10.59. 51,763 shares of the company’s stock were exchanged, compared to its average volume of 105,114. The business has a 50-day moving average price of $10.89 and a two-hundred day moving average price of $10.62. Olympus has a 52-week low of $8.08 and a 52-week high of $13.73.

About Olympus

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.